CiToxLAB increases capabilities in reprotoxicology and juvenile studies
Appoints Paul Barrow as director of scientific projects and client consulting
Barrow has more than 30 years’ experience in preclinical safety testing, gained through working for the pharmaceutical industry and CROs in France, the UK and Italy.
Most recently Barrow was a director of toxicology at Ricerca Biosciences. In more than 10 years at Ricerca, he collaborated with more than 100 clients from the pharmaceutical, biotech, chemical and food industries to devise and execute non-clinical regulatory submission packages and to address pre- and post-marketing safety issues.
Barrow is a member of the Society of Toxicology, the Teratology Society, the European Teratology Society, Eurotox and is a European Registered Toxicologist.
You may also like
Research & Development
Corteria Pharmaceuticals initiates Phase II trial in heart failure and Phase I trial in obesity
Corteria, a clinical-stage biopharmaceutical company focused on the development of transformative therapies for heart failure and obesity, announces the clinical advancement of its two first-in-class corticotropin‑releasing factor receptor 2 (CRF2) agonists: COR‑1167 and COR‑1389